-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Rochester, Minneso.
The researchers are currently investigating whether immunotherapy is beneficial in patients without stage 4 metastatic disea.
"The current standard of care for patients with non-metastatic gastroesophageal cancer includes preoperative chemotherapy plus radiation, followed by surgical removal of the primary tumor and surrounding lymph nodes," said .
.
"Patients who have experienced this total eradication appear to have a higher chance of cure," .
"If these results can be confirmed in a larger, separate clinical trial, the combination of immunotherapy with standard chemoradiotherapy and surgery could become the new standard for patients with non-metastatic gastroesophageal cancer," said .
.